Home › Funds › Lumbard & Kellner, LLC › ETON
Lumbard & Kellner, LLC position in ETON
ETON PHARMACEUTICALS INC · Health Care
Lumbard & Kellner, LLC reported holding 173,263 shares of ETON (ETON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$8.9M, representing 2.53% of its reported portfolio and ranking #12 among its reported holdings. Lumbard & Kellner, LLC has disclosed ETON holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Lumbard & Kellner, LLC's ETON position evolved
Lumbard & Kellner, LLC first disclosed a stake in ETON in Q3 2025 at 176,300 shares (US$3.8M). The position peaked in Q3 2026 at 173,263 shares, worth US$8.9M. Across 5 filings, Lumbard & Kellner, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 173,263 shares valued at US$8.9M — a reduction of -2,646 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 176.30K | $3.83M | New |
| Q4 2025 | 174.94K | $2.96M | Reduce |
| Q1 2026 | 175.91K | $4.34M | Add |
| Q2 2026 | 175.91K | $6.37M | Hold |
| Q3 2026 | 173.26K | $8.92M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ETON and 13F data
ETON (ETON PHARMACEUTICALS INC) is a Health Care company. 75 other funds we track also report a position in ETON — the largest reported positions include Opaleye Management Inc. (US$103.5M), EcoR1 Capital, LLC (US$78.6M), Nantahala Capital Management, LLC (US$42.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETON
- Opaleye Management Inc. 2.86M sh · $103.53M · Q2 2026
- EcoR1 Capital, LLC 2.17M sh · $78.62M · Q2 2026
- Nantahala Capital Management, LLC 1.18M sh · $42.57M · Q2 2026
- Westside Investment Management, Inc. 401.38K sh · $20.67M · Q3 2026
- National Philanthropic Trust 492.11K sh · $17.81M · Q2 2026
- Pillsbury Lake Capital LLC 387.16K sh · $14.02M · Q2 2026
- Panoramic Capital, LLC 208.19K sh · $7.54M · Q2 2026
- CANNELL CAPITAL LLC 170.75K sh · $6.18M · Q2 2026
- Prospect Capital Advisors, LLC 157.20K sh · $5.69M · Q2 2026
- Aristides Capital LLC 145.41K sh · $5.26M · Q2 2026
- PRELUDE CAPITAL MANAGEMENT, LLC 137.57K sh · $4.98M · Q2 2026
- Bridge City Capital, LLC 86.77K sh · $4.47M · Q3 2026
More on Lumbard & Kellner, LLC
FAQ
How long has Lumbard & Kellner, LLC held ETON?
Lumbard & Kellner, LLC has disclosed ETON holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Lumbard & Kellner, LLC's current position in ETON?
As of Q3 2026, Lumbard & Kellner, LLC holds 173.26K shares of ETON (ETON PHARMACEUTICALS INC), valued at $8.92M, representing 2.53% of its reported portfolio and ranking #12.
Has Lumbard & Kellner, LLC been buying or selling ETON?
In the latest 13F filing (Q3 2026), Lumbard & Kellner, LLC reduced its position in ETON. The position peaked in Q3 2026 at 173.26K shares.
Which other funds hold ETON?
Other major institutional holders of ETON include Opaleye Management Inc., EcoR1 Capital, LLC, Nantahala Capital Management, LLC, among 75 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.